CD55 anticorps

N° du produit ABIN610152

Cet anticorps anti-CD55 est un anticorps Souris Monoclonal détectant CD55 dans FACS et IHC. Adapté pour Humain. Ce Primary Antibody a été cité dans 2+ publications.

Aperçu rapide pour CD55 anticorps (ABIN610152)

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD55 est non-conjugé

Application: Flow Cytometry (FACS), Immunohistochemistry (IHC)

Clone: 67

Détail du produit anti-CD55 anticorps

Specificité: CD55 Molecule of 70 kd.

Purification: Protein A purified

Immunogène: Human monocytes.

Type of Immunogen: Cells

Isotype: IgG1 kappa

Information d'application

Indications d'application: Approved: Flo, IHC

Usage: The applications listed have been tested for the unmodified form of this product. Other forms have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: 50 mM sodium phosphate,  pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride

Agent conservateur: Azide free

Conseil sur la manipulation: Do not freeze. Open under aseptic conditions.

Stock: 4 °C

Stockage commentaire: Store at 4°C. Do not freeze. Open under aseptic conditions.

Références pour anticorps anti-CD55 (ABIN610152)

Rizzo, Kraft, Watkins, Levitan, Romero: "Agonist-dependent traffic of raft-associated Ras and Raf-1 is required for activation of the mitogen-activated protein kinase cascade." dans: The Journal of biological chemistry, Vol. 276, Issue 37, pp. 34928-33, (2001) (PubMed).

Bondzi, Grant, Krystal: "A novel assay for the measurement of Raf-1 kinase activity." dans: Oncogene, Vol. 19, Issue 43, pp. 5030-3, (2000) (PubMed).

Détails sur CD55

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Autre désignation: CD55

Sujet: Name/Gene ID: CD55

Synonyms: CD55, CD55 antigen, Decay-accelerating factor, TC, CR, CROM, DAF

ID gène: 1604

UniProt: P08174

Pathways: Système du Complément, Regulation of Leukocyte Mediated Immunity